NovaBridge Biosciences officer files Form 3

NovaBridge Biosciences officer Chu Denny Hsueh Wen filed a Form 3 as an officer of the company.

Rhea-AI Filing Summary

NovaBridge Biosciences officer Chu Denny Hsueh Wen filed a Form 3 as an officer of the company. The filing lists no reportable transactions, with buy, sell, acquire, dispose, exercise, gift, tax withholding, and restructuring counts all shown as zero in this excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does NovaBridge Biosciences (NBP) Form 3 for Chu Denny Hsueh Wen show?

The Form 3 shows that officer Chu Denny Hsueh Wen has filed as an officer of NovaBridge Biosciences. In this excerpt, no buy, sell, or derivative transactions are reported, and all transaction counters are listed as zero.

Are any NovaBridge Biosciences (NBP) insider share purchases or sales reported in this Form 3?

No insider share purchases or sales are reported in this Form 3 excerpt. The transaction summary shows buyCount, sellCount, acquireCount, disposeCount, and netBuySellShares all at zero, indicating no reportable trading activity in this filing segment.

Does the NovaBridge Biosciences (NBP) Form 3 include derivative positions for Chu Denny Hsueh Wen?

The excerpted Form 3 shows no derivative positions for Chu Denny Hsueh Wen. The derivativeSummary is empty, derivativeTransactionCount is zero, and exerciseCount and exerciseShares are also zero in the transaction summary section provided.

What role does Chu Denny Hsueh Wen have at NovaBridge Biosciences (NBP) in this Form 3?

The Form 3 identifies Chu Denny Hsueh Wen as an officer of NovaBridge Biosciences, with the officer title indicated as “See Remarks.” No further role detail is included in the provided excerpt of the filing data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 08:08 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chu Denny Hsueh Wen

(Last) (First) (Middle)

C/O NOVABRIDGE BIOSCIENCES,

2440 RESEARCH BOULEVARD, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NovaBridge Biosciences [ NBP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

EVP, Head of Strategic Partnership Exhibit List: Ex. 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Xi-Yong (Sean) Fu as attorney-in-fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)